tiprankstipranks
Stoke Therapeutics (STOK)
NASDAQ:STOK
US Market
STOK
Stoke Therapeutics
RESEARCH TOOLSreports
Want to see STOK full AI Analyst Report?

Stoke Therapeutics (STOK) Stock News & Sentiment

472 Followers
Stoke Therapeutics: Buy Rating Reiterated as Phase 3 Dravet Program Advances; $60 Price Target Maintained
Premium
Ratings
Stoke Therapeutics: Buy Rating Reiterated as Phase 3 Dravet Program Advances; $60 Price Target Maintained
15d ago
STOK
Analyst Reiterates Buy on Stoke Therapeutics, Maintains $40 Price Target on Robust Dravet Data and Phase 3 Progress
Premium
Ratings
Analyst Reiterates Buy on Stoke Therapeutics, Maintains $40 Price Target on Robust Dravet Data and Phase 3 Progress
16d ago
STOK
Werber Reiterates Buy on Strong EMPEROR Phase 3 Progress, Durable Zorevunersen Data and Solid Cash Runway Through 2028
Premium
Ratings
Werber Reiterates Buy on Strong EMPEROR Phase 3 Progress, Durable Zorevunersen Data and Solid Cash Runway Through 2028
16d ago
STOK
De-Risked Phase 3 Design and Durable Efficacy Support Buy Rating on Stoke Therapeutics’ Zorevunersen
Premium
Ratings
De-Risked Phase 3 Design and Durable Efficacy Support Buy Rating on Stoke Therapeutics’ Zorevunersen
1M ago
STOK
Advancing Zorevunersen in Dravet Syndrome: Late‑Stage Trial Clarity and Regulatory Momentum Support Buy Rating on Stoke Therapeutics
Premium
Ratings
Advancing Zorevunersen in Dravet Syndrome: Late‑Stage Trial Clarity and Regulatory Momentum Support Buy Rating on Stoke Therapeutics
1M ago
STOK
Stoke Therapeutics Adds Veteran Leader to Board, R&D Oversight
Premium
Company Announcements
Stoke Therapeutics Adds Veteran Leader to Board, R&D Oversight
2M ago
8K
STOK
STOK Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
STOK Earnings this Week: How Will it Perform?
3M ago
STOK
More STOK News >

STOK News on the Web

Stoke Therapeutics Grants New Equity Awards to Fuel Talent Pipeline—What’s Behind the Latest Inducement Grants?
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK) and Progyny (PGNY)
TipRanks News
Neutral
Stoke Therapeutics Q1 Earnings Call Highlights
MarketBeat
Bullish
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Genelux Corp. (GNLX) and Celldex (CLDX)
TipRanks News
Bullish
Stoke Therapeutics: Buy Rating Reiterated as Phase 3 Dravet Program Advances; $60 Price Target Maintained
TipRanks News
Bullish
Stoke Therapeutics (STOK) Gets a Buy from Wedbush
TipRanks News
Bullish
Analyst Reiterates Buy on Stoke Therapeutics, Maintains $40 Price Target on Robust Dravet Data and Phase 3 Progress
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), Guardant Health (GH) and Stoke Therapeutics (STOK)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
STOK
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is STOK’s Media Buzz Sentiment?
1 articles about STOK were published this week. In an average week, 3.25 articles are published.
    What is STOK’s weekly average amount of articles?
    In an average week, 3.25 articles about STOK are published.
      What is STOK’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      TLSATiziana Life Sciences
      Showing the stocks with the most bullish news sentiment over the past week